ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 950,17
0,11%
Dow Jones
44 544,66
-0,75%
DAX
21 732,05
0,01%
Brent Oil
76,385
0,00%
Bitcoin
98 484,44
-2,14%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. LAVA Therapeutics NV (LVTX) Cours

LAVA Therapeutics NV

LAVA Therapeutics NV (LVTX)

NASDAQ
0,98
0,0088
(0,91%)
Fermé 02 Février 10:00PM
Retardé de 15 minutes
0,98
0,00
(0,00%)
Après les heures de négociation: 10:00PM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,98
Prix Achat
0,94
Prix Vente
1,02
Volume échangé
24 228
0,9502 Fourchette du Jour 1,03
0,8807 Plage de 52 semaines 6,47
Cap du marché
25,763M
Clôture Veille
0,9712
Ouverture
0,96
Dernière Transaction
20
@
0.98
Dernière heure de transaction
Volume financier
US$ 23 794
VWAP
0,982104
Volume moyen (3 m)
112 807
Actions en circulation
26 289 087
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,61
Bénéfice par action (BPA)
-1,6
Chiffre d'affairess
6,77M
Bénéfice net
-41,97M

À propos de LAVA Therapeutics NV

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells. LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.lavatherapeutics.com
Siège social
Utrecht, Utrecht, Nld
Fondé
-
LAVA Therapeutics NV est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker LVTX. Le dernier cours de clôture d'LAVA Therapeutics NV était de US$0,97. Au cours de la dernière année, les actions de LAVA Therapeutics NV ont été négociées dans une fourchette de prix de US$ 0,8807 à US$ 6,47.

LAVA Therapeutics NV compte actuellement 26 289 087 actions en circulation. La capitalisation boursière d'LAVA Therapeutics NV est de US$25,53 million. LAVA Therapeutics NV a un ratio cours/bénéfice (ratio PE) de -0.61.

LVTX Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

02 Janvier 2025
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

10 Décembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

20 Août 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

06 Juin 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

21 Mai 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

16 Novembre 2023
Edgar (US Regulatory)

LAVA Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

UTRECHT, The Netherlands and PHILADELPHIA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), an immuno-oncology company focused on developing its proprietary Gammabody™...

06 Septembre 2023
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

22 Août 2023
Edgar (US Regulatory)

LAVA Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results

Significant progress with lead program LAVA-1207 in mCRPC reaching dose level 8Significant progress with collaborators including selection of lead candidate by Janssen Biotech and IND clearance...

22 Août 2023
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

15 Août 2023
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.03673.890596840880.94330.9890.92230710.95984295CS
4-0.05-4.854368932041.031.120.9117746880.99885153CS
12-0.86-46.73913043481.8420.88071128071.21640789CS
26-1.23-55.65610859732.212.210.8807780351.43369955CS
52-0.75-43.35260115611.736.470.88073350442.78339014CS
156-4.77-82.95652173915.757.380.88073110223.03227852CS
260-10.5-91.463414634111.4817.20.88072600453.44352837CS

LVTX - Frequently Asked Questions (FAQ)

What is the current LAVA Therapeutics NV share price?
The current share price of LAVA Therapeutics NV is US$ 0,98
How many LAVA Therapeutics NV shares are in issue?
LAVA Therapeutics NV has 26 289 087 shares in issue
What is the market cap of LAVA Therapeutics NV?
The market capitalisation of LAVA Therapeutics NV is USD 25,53M
What is the 1 year trading range for LAVA Therapeutics NV share price?
LAVA Therapeutics NV has traded in the range of US$ 0,8807 to US$ 6,47 during the past year
What is the PE ratio of LAVA Therapeutics NV?
The price to earnings ratio of LAVA Therapeutics NV is -0,61
What is the cash to sales ratio of LAVA Therapeutics NV?
The cash to sales ratio of LAVA Therapeutics NV is 3,81
What is the reporting currency for LAVA Therapeutics NV?
LAVA Therapeutics NV reports financial results in USD
What is the latest annual turnover for LAVA Therapeutics NV?
The latest annual turnover of LAVA Therapeutics NV is USD 6,77M
What is the latest annual profit for LAVA Therapeutics NV?
The latest annual profit of LAVA Therapeutics NV is USD -41,97M
What is the registered address of LAVA Therapeutics NV?
The registered address for LAVA Therapeutics NV is YALELAAN 62, UTRECHT, UTRECHT, 3584 CM
What is the LAVA Therapeutics NV website address?
The website address for LAVA Therapeutics NV is www.lavatherapeutics.com
Which industry sector does LAVA Therapeutics NV operate in?
LAVA Therapeutics NV operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,72M
REBNReborn Coffee Inc
US$ 3,31
(63,05%)
55,54M
FCUVFocus Universal Inc
US$ 5,87
(56,62%)
1,73M
SOPASociety Pass Inc
US$ 1,54
(56,50%)
13,82M
CYCNCyclerion Therapeutics Inc
US$ 3,92
(54,33%)
82,39M
ENVBEnveric Biosciences Inc
US$ 2,0899
(-46,41%)
1,57M
NIVFNewGenIvf Group Ltd
US$ 0,1489
(-42,51%)
14,8M
GLSTGlobal Star Acquisition Inc
US$ 8,83
(-39,10%)
23,89k
PRPHProPhase Labs Inc
US$ 0,2633
(-38,02%)
872,46k
SPGCSacks Parente Golf Inc
US$ 0,5601
(-37,86%)
7,27M
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,72M
NVDANVIDIA Corporation
US$ 120,07
(-3,67%)
388,54M
RIMEAlgorhythm Holdings Inc
US$ 0,02565
(5,12%)
338,75M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0355
(-11,25%)
236,29M
CLEUChina Liberal Education Holdings Ltd
US$ 0,1938
(30,77%)
234,8M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
LVTX
LAVA Therapeutics NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces